INSP Inspire Medical Systems, Inc.

NYSE inspiresleep.com


$ 73.80 $ 1.69 (2.35 %)    

Monday, 03-Nov-2025 19:37:02 EST
QQQ $ 629.78 $ -3.11 (-0.49 %)
DIA $ 472.70 $ -2.66 (-0.56 %)
SPY $ 681.88 $ -2.29 (-0.33 %)
TLT $ 89.68 $ 0.07 (0.08 %)
GLD $ 366.72 $ 0.05 (0.01 %)
$ 73.71
$ 72.06
$ 68.00 x 11
$ 83.00 x 144
-- - --
$ 70.77 - $ 216.01
2,193,877
na
2.14B
$ 1.27
$ 48.07
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-03-2025 09-30-2025 10-Q
2 08-04-2025 06-30-2025 10-Q
3 05-05-2025 03-31-2025 10-Q
4 02-10-2025 12-31-2024 10-K
5 11-04-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 02-09-2024 12-31-2023 10-K
9 11-07-2023 09-30-2023 10-Q
10 08-01-2023 06-30-2023 10-Q
11 05-02-2023 03-31-2023 10-Q
12 02-10-2023 12-31-2022 10-K
13 11-01-2022 09-30-2022 10-Q
14 08-02-2022 06-30-2022 10-Q
15 05-03-2022 03-31-2022 10-Q
16 02-15-2022 12-31-2021 10-K
17 11-02-2021 09-30-2021 10-Q
18 08-03-2021 06-30-2021 10-Q
19 05-04-2021 03-31-2021 10-Q
20 02-24-2021 12-31-2020 10-K
21 11-02-2020 09-30-2020 10-Q
22 08-04-2020 06-30-2020 10-Q
23 05-05-2020 03-31-2020 10-Q
24 02-25-2020 12-31-2019 10-K
25 11-05-2019 09-30-2019 10-Q
26 08-06-2019 06-30-2019 10-Q
27 05-07-2019 03-31-2019 10-Q
28 02-26-2019 12-31-2018 10-K
29 11-06-2018 09-30-2018 10-Q
30 08-07-2018 06-30-2018 10-Q
31 06-07-2018 03-31-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 inspire-medical-systems-raises-fy2025-gaap-eps-guidance-from-040-050-to-090-100-vs-045-est-affirms-fy2025-sales-guidance-of-900000m-910000m-vs-903814m-est

Inspire Medical Systems (NYSE:INSP) raises FY2025 GAAP EPS guidance from $0.40-$0.50 to $0.90-$1.00 vs $0.45 analyst estimate. ...

 inspire-medical-systems-q3-adj-eps-038-beats-019-estimate-sales-224501m-beat-220467m-estimate

Inspire Medical Systems (NYSE:INSP) reported quarterly earnings of $0.38 per share which beat the analyst consensus estimate of...

 jefferies-downgrades-inspire-medical-systems-to-hold-lowers-price-target-to-85

Jefferies analyst Michael Sarcone downgrades Inspire Medical Systems (NYSE:INSP) from Buy to Hold and lowers the price targe...

 truist-securities-maintains-hold-on-inspire-medical-systems-lowers-price-target-to-90

Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a Hold and lowers the price ta...

 inspire-medical-publishes-inspire-v-clinical-outcomes-data-from-singapore-clinical-study-and-limited-market-release-in-us-including-single-site-experience-at-two-leading-centers-data-to-be-presented-at-aao-hns-and-isss-meetings

Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercializat...

 evercore-isi-group-maintains-outperform-on-inspire-medical-systems-lowers-price-target-to-125

Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and lowers the p...

 kenneth-griffin-reports-58-passive-stake-in-inspire-medical-systems-as-of-sept-29

https://www.sec.gov/Archives/edgar/data/1609550/000110465925097180/xslSCHEDULE_13G_X01/primary_doc.xml

 ubs-downgrades-inspire-medical-systems-to-neutral-lowers-price-target-to-89

UBS analyst Danielle Antalffy downgrades Inspire Medical Systems (NYSE:INSP) from Buy to Neutral and lowers the price target...

Core News & Articles

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.Mont-Saint-Guibert, Belgium – September 15, 2025,...

 evercore-isi-group-initiates-coverage-on-inspire-medical-systems-with-outperform-rating-announces-price-target-of-150

Evercore ISI Group analyst Daniel Markowitz initiates coverage on Inspire Medical Systems (NYSE:INSP) with a Outperform rati...

 inspire-medical-systems-affirms-fy2025-gaap-eps-guidance-of-040-050-vs-227-est-affirms-fy2025-sales-guidance-of-900000m-910000m-vs-949364m-est

Inspire Medical Systems (NYSE:INSP) affirms FY2025 GAAP EPS guidance from $0.40-$0.50 to $0.40-$0.50 vs $2.27 analyst estimate....

 inspire-medical-cfo-rick-buchholz-to-step-down-by-year-end-will-stay-in-advisory-role-through-february-2026

Inspire Medical Systems, Inc. (NYSE:INSP) (Inspire), a medical technology company focused on the development and commercializat...

 leerink-partners-maintains-market-perform-on-inspire-medical-systems-lowers-price-target-to-97

Leerink Partners analyst Mike Kratky maintains Inspire Medical Systems (NYSE:INSP) with a Market Perform and lowers the pric...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION